Protera Biosciences
PrivateLast Round
Series A
Jul 28, 2021
Total Funding Raised
$15.6M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Protera Biosciences operates in Healthcare & Life Sciences and is based in Paris. Its latest recorded funding round was a Series A round in July 2021.
Protera Biosciences is a biotechnology company that utilizes an AI-driven platform, madi™, to engineer and design new proteins for various applications, including food, agriculture, and human health.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Sustainable Materials, Vertical SaaS
Business Model
B2B
Customer Profile
Services & Consulting, Subscription SaaS
AI Layer
Infrastructure
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Protera Biosciences Comparables
Compare Protera Biosciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Shiru | 84% | |
| The Live Green Co | 79% | |
| Nuritas | 78% |
For institutional investors. Book with your work email.
Protera Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jul 28, 2021 | ||||
| Series A | Jun 9, 2020 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Protera Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| ICL Planet Startup Hub | Series A |
| Grupo Bimbo | Series A |
| IndieBio | Accelerator |
| Sofinnova Partners | Series A |
| SOSV | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 20, 2026
Monthly visitors grew 485% MoM, from 581 to 3.4K.
For institutional investors. Book with your work email.
Protera Biosciences Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Protera Biosciences's valuation, stock price, and market status.
Is Protera Biosciences a public or private company?
Protera Biosciences is a private company.
What is the current stock price of Protera Biosciences?
Protera Biosciences is a private company, so its shares have no public market price. Caplight tracks Protera Biosciences's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Protera Biosciences worth (valuation)?
Valuation information for Protera Biosciences is not publicly available.
Can I buy Protera Biosciences stock?
Protera Biosciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Protera Biosciences's last funding round?
Protera Biosciences's most recent funding round was Series A on July 28, 2021.
Who are the main investors in Protera Biosciences?
Key investors in Protera Biosciences include Sofinnova Partners.
Will Protera Biosciences IPO soon?
No public IPO plans have been announced for Protera Biosciences.
How can I track Protera Biosciences secondary market activity?
Caplight tracks bids, offers, and trades in Protera Biosciences's shares on secondary markets.